AZINTUXIZUMAB
UNII 8UAH8N2SAS

Substance Identification & Data

This profile provides standardized clinical and technical data for Azintuxizumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 8UAH8N2SAS.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1826819-57-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
8UAH8N2SAS
CAS Registry Number
1826819-57-1
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
AZINTUXIZUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C171742
National Cancer Institute reference terminology for clinical and research data.
INN ID
10498
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Azintuxizumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

AZINTUXIZUMAB

Common Names & Synonyms

AZINTUXIZUMAB [INN]

Systematic Nomenclature

IMMUNOGLOBULIN G1, ANTI-(HUMAN CD319 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL PR-1471272 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL PR-1471272 LIGHT CHAIN, DIMER

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus